Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Antibodies, large molecule drug structure

Whole proteins, including monoclonal antibodies, are the fastest-growing class of therapeutics. Compared with traditional small molecule drugs, much additional analysis is necessary for their development and production due to their large size and complex structure. The protein construct and its formulation have to be optimized during development, and its structural integrity must be closely monitored during production. [Pg.393]

See other pages where Antibodies, large molecule drug structure is mentioned: [Pg.647] [Pg.16] [Pg.261] [Pg.93] [Pg.49] [Pg.37] [Pg.321] [Pg.378] [Pg.198] [Pg.127] [Pg.332] [Pg.407] [Pg.738] [Pg.1501] [Pg.285] [Pg.261] [Pg.297] [Pg.153] [Pg.183] [Pg.54] [Pg.150] [Pg.426] [Pg.106] [Pg.885] [Pg.118] [Pg.277] [Pg.272] [Pg.247] [Pg.431] [Pg.38] [Pg.908] [Pg.181] [Pg.318] [Pg.1] [Pg.494] [Pg.788] [Pg.247] [Pg.1678] [Pg.244]

See also in sourсe #XX -- [ Pg.106 , Pg.107 , Pg.108 ]

SEARCH

Antibodies antibody molecules

Antibodies molecule

Antibodies, large molecule drug

Antibody structure

Drug molecules

Drug molecules structure

Drug structure

Drug-antibody

Large molecule drugs

Large structures

Molecules large

Molecules structures

Structural molecules